CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
SeraCare Life Sciences has launched three seroconversion panels that provide difficult-to-find patient samples for hepatitis B and HIV.
HBV seroconversion panel PHM938 comprises six undiluted plasma samples from a single donor drawn over a six-day period and is HBV DNA-positive from the first bleed.
HBV seroconversion panel PHM939 provides five undiluted plasma samples from a single donor drawn over a 21-day period and is HBV DNA-positive from the first bleed. The panel allows for challenging members for HBsAg assays and HBeA assays, delivering results for rapid and qualitative HBsAg methods.
HIV-1 seroconversion panel PRB978 provides seven undiluted plasma samples from a single donor and is designed to challenge HIV RNA-positive members on traditional antibody methods.
SeraCare Life Sciences, 800-676-1881